Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Arcalyst
(rilonacept)Orphan drugstandardKiniksa Pharmaceuticals, Ltd.
12.1 Mechanism of Action Rilonacept is an interleukin-1 alpha (IL-1α) and interleukin-1 beta (IL-1β) cytokine trap. Rilonacept blocks IL-1 signaling b...
Browse all Sterile multifocal osteomyelitis with periostitis and pustulosis news →
Gina A Montealegre, M.D., M.D
National Institute of Allergy and Infectious Diseases (NIAID)
📍 CLEVELAND, OH
Avindra Nath, M.D., M.D
National Institute of Neurological Disorders and Stroke (NINDS)
📍 BALTIMORE, MD
View all Sterile multifocal osteomyelitis with periostitis and pustulosis specialists →